5-methyl-1(3H)-isobenzofuran

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异苯并呋喃
• 英文名称: 5-methyl-1(3H)-isobenzofuran
• 英文别名: 5-methyl-2-benzofuran
• 化学式: C₉H₈O
• 分子量: 132.16
• InChiKey: BJCGCTDHYXCSTL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  13.1
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof
  申请人：Unoki Gen

  公开号：US20070173519A1

  公开（公告）日：2007-07-26

  A pyrazolopyrimidine derivative represented by formula (1) and pharmaceutically acceptable salt thereof exhibit excellent inhibitory activity against MAPKAP-K2. Accordingly, medicines containing this compound as an active ingredient are expected to be effective for treating diseases mediated by MAPKAP-K2 such as, for example, inflammatory disorder, autoimmune diseases, destructive osteopathy, cancer and/or tumor growth.

  由式（1）表示的吡唑吡嘧啶衍生物及其药用盐对MAPKAP-K2表现出优异的抑制活性。因此，含有该化合物作为活性成分的药物预计对治疗由MAPKAP-K2介导的疾病，如炎症性疾病、自身免疫疾病、破坏性骨病、癌症和/或肿瘤生长等方面具有有效性。
• QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR
  申请人：Abbvie Deutschland GmbH & Co. KG

  公开号：US20170260158A1

  公开（公告）日：2017-09-14

  The present invention relates to quinoline compounds of formula I wherein the variables are defined as in the claims and the description. The invention further relates to a pharmaceutical composition containing such compounds, to their use as modulators of the 5-HT 6 receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of the 5-HT 6 receptor, and to methods for preventing or treating conditions and disorders which respond to the modulation of the 5-HT 6 receptor.

  本发明涉及公式I的喹啉化合物，其中变量的定义如索引和描述中所述。本发明还涉及含有这种化合物的药物组合物，以及它们作为5-HT6受体调节剂的用途，用于制备用于预防或治疗对5-HT6受体调节有反应的疾病和疾病的药物，以及用于预防或治疗对5-HT6受体调节有反应的疾病和疾病的方法。
• Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof
  申请人：UNOKI Gen

  公开号：US20090054472A1

  公开（公告）日：2009-02-26

  A pyrazolopyrimidine derivative represented by formula (1) and pharmaceutically acceptable salt thereof exhibit excellent inhibitory activity against MAPKAP-K2. Accordingly, medicines containing this compound as an active ingredient are expected to be effective for treating diseases mediated by MAPKAP-K2 such as, for example, inflammatory disorder, autoimmune diseases, destructive osteopathy, cancer and/or tumor growth.

  式（1）所表示的吡唑并嘧啶衍生物及其药学上可接受的盐，表现出对MAPKAP-K2的优异抑制活性。因此，含有该化合物作为活性成分的药物预计将对由MAPKAP-K2介导的疾病具有治疗作用，例如，炎症性疾病、自身免疫性疾病、破坏性骨病、癌症和/或肿瘤生长。
• PYRAZOLOPYRIMIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
  申请人：Teijin Pharma Limited

  公开号：EP1864986A1

  公开（公告）日：2007-12-12

  A pyrazolopyrimidine derivative represented by formula (1) and pharmaceutically acceptable salt thereof exhibit excellent inhibitory activity against MAPKAP-K2. Accordingly, medicines containing this compound as an active ingredient are expected to be effective for treating diseases mediated by MAPKAP-K2 such as, for example, inflammatory disorder, autoimmune diseases, destructive osteopathy, cancer and/or tumor growth.

  由式（1）代表的吡唑嘧啶衍生物及其药学上可接受的盐对 MAPKAP-K2 具有极佳的抑制活性。因此，含有这种化合物作为活性成分的药物有望有效治疗由 MAPKAP-K2 介导的疾病，例如炎症性疾病、自身免疫性疾病、破坏性骨病、癌症和/或肿瘤生长。
• METHOD FOR PRODUCING POLYISOTHIANAPHTHENE ELECTROCONDUCTIVE POLYMER
  申请人：Showa Denko K.K.

  公开号：EP3564290A1

  公开（公告）日：2019-11-06

  The present invention relates to (i) a method of producing a conductive polymer, comprising polymerizing at least one of compounds (A1) represented by the formula (1) disclosed in the specification in the presence of a compound (B) having sulfo group; (ii) a method of producing a conductive polymer, comprising polymerizing at least one compound selected from a group consisting of at least one compound (A2) represented by the formula (2); and (iii) a method of producing a conductive polymer, comprising copolymerizing at least one compound (A1) and at least one compound selected from a group consisting of at least one compound (A2). The method of the present invention is a method for producing a one-liquid type conductive polymer in which it is possible to easily adjust the solvent affinity, the solubility, and other such aspects of performance according to the purpose.

  本发明涉及(i)生产导电聚合物的方法，包括在具有磺基的化合物(B)存在下聚合至少一种由说明书中公开的式(1)代表的化合物(A1)；(iii) 一种生产导电聚合物的方法，包括将至少一种化合物(A1)和至少一种选自至少 一种化合物(A2)的化合物共聚。本发明的方法是一种生产单液型导电聚合物的方法，在这种方法中，可以根据目的轻松调整溶剂亲和性、溶解性和其他性能方面。